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Objective: To explore the antidiabetic and the antidiarrhoeal effects of ethanolic extracts
of Cynodon dactylon Pers. aerial parts (EECA) in Wistar rats.
Methods: To assess the antidiabetic activity of EECA, oral glucose tolerance test
(OGTT) model and alloxan induced diabetic test (AIDT) model were performed. The
EECA was used at the doses of 2 g/kg, 1 g/kg and 500 mg/kg body weight in OGTT
model and 1.5 g/kg was used for AIDT model. Castor oil-induced diarrhoeal model and
gastrointestinal motility test with barium sulphate milk model were performed for eval-
uating the antidiarrhoeal effects at doses of 1 g/kg, 750 mg/kg respectively.
Results: The dose 2 g/kg in OGTT and 1.5 g/kg in AIDT model blood glucose levels
decreased signiﬁcantly (P < 0.01) in Wistar rats that showed antidiabetic effect of EECA.
After administration of EECA at the dose of 1 g/kg, the extract showed signiﬁcant
(P < 0.05) antidiarrhoeal activity in castor oil-induced diarrhoeal model. The results were
also signiﬁcant (P < 0.05) in barium sulphate milk model for the same dose by using
above mentioned animals.
Conclusions: It is concluded that EECA contains both antidiabetic and the antidiarrhoeal
properties.1. Introduction
Diabetes mellitus is a continual metabolic disorder which
leads to the deﬁciency in the production of insulin by the
pancreas and has resulted signiﬁcant morbidity and mortality
because of microvascular (retinopathy, neuropathy, and ne-
phropathy) and macrovascular complications (heart attack,
stroke and peripheral vascular disease) of patients [1]. Now it is
expected that all over the world at least 171 million people have
diabetes, and this number is probable to more than double by
2030. In addition, per year nearly 3.2 million deaths are
attributable to complications of diabetes; six deaths every
minute [2]. On the other hand diarrhoeal diseases are one of
the major causes of morbidity and mortality in developing
countries and each year 1.5 million children who are underﬁve years old are died because of the disease [3]. Now existing
available drugs for the treatment of diabetes and diarrhoea are
not free from side effects. So, it is very important to identify
and assess usually available natural drugs as alternatives to
currently used antidiabetic and antidiarrhoeal drugs. In this
view, plants are cheaper and much effective, and are
completely free from adverse effects. Traditionally a number
of medicinal plants are used as antidiabetic and antidiarrhoeal
agent, and some of them have shown their efﬁcacy through
pharmacological evaluation. In addition, depending on
traditional medical practices, the World Health Organization
encouraged to study for the treatment and prevention of
diabetes and diarrhoeal diseases [3,4].
Cynodon dactylon Pers. (C. dactylon) (Bengali name “dubla”,
“durbaghas”, English name bermuda grass) belonging to the
family Poaceae is a slender, perennial creeping grass forming
matted tufts with slender erect ﬂowering branches. The plant is
vulnerary, expectorant and styptic. It is a very common plant in
Bangladesh and contains various medicinal properties [5]. This
plant has been used as anti-inﬂammatory, anticystitis, antihyper-
tensive [6]. The juice of the plant is astringent and frequently usedpen access article under the CC BY-NC-ND
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of catarrhal ophthalmia, dropsy, insanity, hysteria, epilepsy,
chronic diarrhoea, and dysentery. The rhizome of the plants is
used as an anti-inﬂammatory, antiemetic, purifying agent,
diuretic and also in the treatment of dysentery. The plant,
C. dactylon is a folk medicine for anasarca, calculus, carbuncles,
cancer, cough, hypertension, snakebites, gout, fever, stones, skin
diseases, and rheumatic infections [7]. The present study aims to
explore the antidiabetic and antidiarrhoeal activity of ethanolic
extract of aerial parts of C. dactylon in normal Wistar rat, which
is ﬁrst report from Bangladesh.
2. Materials and methods
2.1. Plant materials and extraction
The aerial parts of C. dactylon were collected from
Bangladesh Council of Scientiﬁc and Industrial Research
(BCSIR) laboratories, Chittagong, Bangladesh campus in
September 2013. The voucher specimen (S-0026/2013) of this
plant was deposited at the Herbarium, Industrial Botany
Research Division, BCSIR Laboratories, Chittagong,
Bangladesh. The collected plants were washed, chopped, dried,
powdered, extracted with 98.00% ethanol and concentrated with
the help of rotary vacuum evaporator. In terms of dried starting
material the yield of the extract was 0.99% (w/w) that was
preserved in refrigerator at 4 C for using the experiment
purposes.
2.2. Experimental animals
To evaluate the antidiabetic and the antidiarrhoeal activity of
ethanolic extracts of C. dactylon aerial parts (EECA), male
Wistar rats weighting between (180 ± 10) g were brought from
animal house of BCSIR Laboratories, Chittagong. Standard
laboratory conditions were maintained for the experiments.
Drinking water ad libitum and standard diet were supplied for
the animals. The ethical guidelines of Pharmacological Research
Division, BCSIR Laboratories, Chittagong, Bangladesh were
followed in all aspect of animal care.
2.3. Chemicals
Commercially available analytical grade chemicals and drugs
like alloxan tetrahydrate (Merck, India), barium sulfate (Merck,
India Ltd.), castor oil (Shengyang Kaiyingsheng Chemical Co.
Ltd., China), diethyl ether (Sigma–Aldrich, India), glibencla-
mide [Marion Roussel Ltd., (Aventis, Bangladesh)], glucose
powder (Dextrose monohydrase, GlaxoSmithKline, Chittagong,
Bangladesh Ltd.), Loperamide (Opsonin, Bangladesh) and
Tween 80 [Polyoxyethylene (20), Loba Chemie Pvt. Ltd., India]
were used for this experiment.
2.4. Experiments
2.4.1. Oral glucose tolerance test (OGTT) model
Overnight fasted normal albino Wistar rats were used for the
OGTT as per maintained the reported method [8]. The rats were
randomly divided into ﬁve groups marked as Group I to V. Eachgroup contains ﬁve rats. Group I and Group II assigned as
control and positive control group respectively. Groups III to
V recognized as treated group for EECA treatment. Blood was
collected from the tip of tail and blood glucose level (BGL)
was measured of all groups of rats with the help of a blood
glucose meter (Accu-chek active, Roche Diagnostics,
Germany). After then only 2 mL/rat distilled water was
supplied for control group and reference antidiabetic drug
glibenclamide was given orally at a dose of 4.15 mg/kg body
weight for positive control group. Groups III, IV and V of rats
were treated orally with EECA at the doses of 2 g/kg, 1 g/kg
and 500 mg/kg body weight respectively. After 30 min of
water, drug and extract administration BGL was measured.
Then 10 g/kg (body weight) glucose solution was provided
orally for all these animals and BGL was observed of all rats
after 30, 60, and 120 min of glucose administration.
2.4.2. Alloxan induced diabetic test (AIDT) model
With the help of intraperitoneal injection, alloxan tetrahy-
drate (100 mg/kg i.p.) was provided in overnight fasted male
Wistar rats for inducing diabetes. After 24 h BGL was measured
and separated them who were contained BGL more than
15 mmol/L and assigned as diabetic rats. These rats were used
for the experiment. Diabetic induced rats were randomly divided
into three experimental groups and each with ﬁve rats, marked as
Group II to IV. Group II indicated as diabetic control supplied
only distilled water. Reference antidiabetic drug glibenclamide
(4.15 mg/kg) was provided for Group III marked as positive
control. Group IV was treated with EECA at the dose of 1.5 g/
kg. Previously selected Group I marked as control which had no
diabetes. At ﬁrst, BGL of all groups of rats was measured before
administration of water, extract and drug which indicated the
time 0 h, after then water, drug and extract were provided ac-
cording to mentioned group and BGL were determined after 3, 6
and 9 h respectively by following above mentioned system.
During blood collection from experimented rats, diethyl ether
was used for anaesthesia. Favourable humidity and room tem-
perature were maintained for increasing the survival capacity of
experimental rats.
2.4.3. Castor oil-induced diarrhoea (COID) model
Antidiarrhoeal activity of EECA was estimated with COID
model as per reported method [9]. Wistar rats were divided into
four groups by random selection and each group contained ﬁve
rats. Group I assigned as control. Group II marked as positive
control and the rest of Groups III and IV recognized as treated
groups. At ﬁrst, extract and drugs were provided orally and
after 1 h castor oil (2 mL/rat) was supplied for inducing
diarrhoea. Only distilled water (2 mL/rat) was supplied for the
control group and standard drug loperamide (2 mg/kg) was
provided for the positive control group. Treated Groups III
and IV received EECA at the dose of 1 g/kg and 750 mg/kg
respectively. Separate cages were used for each rat and sheets
of paper were placed below the cage for collection of fecal
matters. The presence of stool with ﬂuid material that stained
the paper was placed beneath the cages indicated diarrhoea. At
every hour the numbers of both hard and soft pellets were
counted up to 6 h period for each rat and ﬁnally moisture
content of all faeces was measured.
Table 2
Effect of EECA on alloxan induced model.
Groups 0 h 3 h 6 h 9 h
Group I
(control)
6.78 ± 0.29 6.54 ± 0.51 6.70 ± 0.38 6.14 ± 0.22
Group II
(diabetic control)
19.46 ± 0.59### 22.72 ± 0.99### 24.90 ± 1.06### 29.03 ± 1.81###
Group III
(positive control)
21.44 ± 1.52 16.14 ± 1.74 9.30 ± 1.81** 5.36 ± 0.59***
Group IV
(EECA 1.5 g/kg)
22.64 ± 0.63 19.74 ± 0.82 15.80 ± 0.45** 14.84 ± 0.53**
Values are expressed mean ± SEM; ###: P < 0.001 means signiﬁcant
difference compared diabetic control with control; **: P < 0.01; ***:
P < 0.001 refers to positive control and extract compared with diabetic
control.
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milk (BSM) model for diarrhoea
BSM model was done as per published method [10]. By
random selection Wistar rats (over night fasted) were divided
into four groups each with ﬁve rats. Only distilled water of
2 mL/rat was supplied orally for Group I recognized as
control group. Commercially available reference antidiarrhoeal
drug loperamide at the dose of 2 mg/kg was provided orally
for Group II marked as positive control group. EECA orally
treated at dose of 1 g/kg and 750 mg/kg for Groups III and IV
respectively assigned as treated groups. After 30 min, 2 mL of
10% barium sulfate solution was administered in all groups of
rats. Rats were sacriﬁced after 30 min of extract and drug
administration. Finally, the distance travelled by BSM was
measured and showed as a percentage of the total length of
small intestine (from pylorus to the ileo-cecal junction).
2.5. Statistical analysis
The values of antidiarrhoeal and antidiabetic tests were
expressed as mean ± SEM. Student's t-test was used to analyse
statistical differences between the mean of the various groups.
Microsoft Excel 2007 was used for statistical calculations. Mean
values were considered signiﬁcantly different if P < 0.05,
P < 0.01 and P < 0.001.
3. Results
3.1. Effect of EECA on OGTT model
In the present study, the results of OGTT of EECA on Wistar
rats are documented in the Table 1. In the positive control group
BGL were 4.54, 3.60, 8.66, 6.42 and 2.88 mmol/L whereas the
group received EECA at the dose of 2 g/kg, BGL were 4.98,
4.64, 12.02, 9.00 and 7.36 mmol/L at different times mentioned
in Table 1. It was observed that glibenclamide at dose of 4.15 g/
kg were effective to the decreased BGL in all interval with the
increasing exposure time. On the other hand among three treated
groups (Groups III, IV and V), Group III showed signiﬁcantTable 1
Effect of ethanol extract of C. dactylon aerial parts on OGTT.
Test samples groups Dose
Fasting BGL
(pretreatment)
B
30 m
adm
Control (Group I) 2 mL/rat 4.18 ± 0.34 4.5
Positive control (Group II) 4.15 mg/kg 4.54 ± 0.45 3.6
EECA treated Group III 2 g/kg 4.98 ± 0.34 4.6
Group IV 1 g/kg 4.36 ± 0.24 4.7
Group V 500 mg/kg 4.86 ± 0.34 4.7
Values are expressed mean ± SEM; *: P < 0.05; **: P < 0.01; ***: P < 0.00
control.(P < 0.05 and P < 0.01) result to decrease the BGL at the dose
of 2 g/kg.
3.2. Effect of EECA on AIDT model
The effects of EECA on AIDT model of treated rats are
shown in Table 2. It was observed that the BGL increased
after administration of alloxan in diabetic control group in
all counted intervals at 3, 6 and 9 h respectively. The BGL
of the positive control group were 21.44, 16.14, 9.30 and
5.36 mmol/L at different times mentioned in Table 2.
Whereas the values (BGL) for the plant extract at the dose of
1.5 g/kg were 22.64, 19.74, 15.80 and 14.84 mmol/L.
Compared to control EECA showed effective result in
reduction of BGL in the alloxane induced diabetic rats
(P < 0.01).
3.3. Effect of EECA on COID model
Table 3 enumerated the results of antidiarrhoeal effect of
loperamide and EECA in on Wistar albino rats. Compared to the
control group the results shown that EECA at the dose of 1 g/kg
was effective to inhibit the frequency of wetting faeces (P < 0.01
and P < 0.05) and defecation as well as inhibit the moisture
content of total faeces.Mean blood glucose concentration (mmol/L)
GL after
in extract
inistration
BGL after glucose administration
30 min 60 min 120 min
6 ± 0.16 12.70 ± 1.21 12.08 ± 1.13 10.10 ± 0.58
0 ± 0.34* 8.66 ± 0.58** 6.42 ± 0.58** 2.88 ± 0.34***
4 ± 0.21 12.02 ± 1.59 9.00 ± 1.33* 7.36 ± 0.74**
8 ± 0.18 15.70 ± 1.40 13.52 ± 0.91 9.04 ± 0.86
6 ± 0.19 15.10 ± 0.95 14.70 ± 1.42 10.50 ± 0.73
1 mean signiﬁcant difference compared positive control and extract with
Table 3
Effect of EECA on COID model.
Groups Dose Total faeces
in 6 h
% Inhibition
of defecation
No. of
wet faeces
in 6 h
% Inhibition
of defecation
Water content
of total faeces (g)
Inhibition (%)
of water content
Moisture content
of total faeces (%)
Control (water) 2 mL/rat 21.60 ± 2.07 18.60 ± 4.09 5.71 20.34
Positive control
(loperamide)
2 mg/kg 8.40 ± 0.14*** 61 4.20 ± 0.83** 78 2.90 49.21 10.75
EECA 1 g/kg 15.40 ± 1.14** 29 13.60 ± 1.14* 27 3.72 34.85 13.71
750 mg/kg 21.20 ± 1.92 2 16.00 ± 1.58 14 4.92 13.83 18.13
Values are expressed mean ± SEM; *: P < 0.05; **: P < 0.01; ***: P < 0.001 mean signiﬁcant difference compared positive control and extract with
control.
Table 4
Effect of EECA on gastrointestinal motility with BSM on Wistar rat.
Group Dose Length of
GIT (cm)
Distance
passed by
BaSO4 cm
BaSO4
transverse
(%)
Inhibition
(%)
Control
(distilled water)
2 mL 117.80 ± 6.80 69.00 ± 5.00 58.57
Positive control
(loperamide)
2 mg/kg 113.70 ± 4.50 40.20 ± 12.10 35.38** 39.60
EECA 1 g/kg 106.60 ± 6.17 50.25 ± 8.22 47.12* 19.55
750 mg/kg 103.60 ± 2.38 49.85 ± 9.70 48.12 17.84
Values are expressed mean ± SEM. *: P < 0.05; **: P < 0.01 mean
signiﬁcant difference compared positive control and extract with control.
GIT: Gastro intestinal tract (from pylorus to the ileo-cecal junction).
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The gastrointestinal motility test with BSM of EECA and
loperamide results on Wistar rats are illustrated in Table 4. At
30 min study, the highest reduction of gastrointestinal motility
(from 58.57% to 35.38%) was for loperamide at dose of
2 mg/kg and inhibition of the distance travelled by BaSO4
milk was 39.6%. It was observed that the plant extracts
decreased the distance of gastrointestinal motility of rats that
was moderately signiﬁcant (P < 0.05), from 58.57% (control
group) to 47.12% as well as the inhibition of distance trav-
elled by BaSO4 milk was 19.55% at the dose of 1 g/kg
compared to control.
4. Discussion
The aqueous extract of C. dactylon (whole plant) lowers
BGL around 31% after 4 h of administration in normal rats and
the dose 500 mg/kg was evaluated as the most effective dose
[11]. At the dose of 500 mg/kg after 7 days, the ethanolic extract
of C. dactylon root stalks showed a good antidiabetic activity
against the treated model [12]. The aqueous crude extract of
C. dactylon (whole plant) at the dose of 400 mg/kg showed
signiﬁcant activity to decrease the BGL after 2 h of
administration [13]. The present study, the ethanolic extracts of
the aerial parts of C. dactylon at the dose of 2 g/kg after
120 min the extract showed a signiﬁcant result (P < 0.01 and
P < 0.05) to reduce the BGL with OGTT model as well as
with AIDT model at the dose of 1.5 g/kg after 6 h of
administration.
Methanolic extract of C. dactylon (whole plants) exhibited
considerable reduction in inhibition of castor oil induced diar-
rhoea at the dose of 200 mg/kg and 300 mg/kg [14]. The presentwork with castor oil induced diarrhoea model, the ethanolic
extract of C. dactylon (aerial parts) signiﬁcantly (P < 0.05)
reduced the number of wet faeces and inhibited the total
moisture of total faeces at the dose of 1 g/kg. The plant
extract also decreased the number of stools between 1st and
6th h signiﬁcantly (P < 0.01) at the dose of 1 g/kg compare to
control. In gastrointestinal motility with charcoal meal test,
methanolic extract of C. dactylon (whole plant) also expressed
signiﬁcant result against dysentery [14]. The present result with
BSM model, at the dose of 1 g/kg of C. dactylon ethanolic
extract (aerial parts) signiﬁcantly decreased (P < 0.05) in
intestinal transmit and inhibited by 19.55% compared to control.
Alloxan as well as over loaded glucose damage the beta cells
of pancreas and create diabetes due to selectively inhibiting
glucose-induced insulin secretion and hampering the activity of
the beta cell glucose sensor glucokinase [15].
Castor oil reduces normal ﬂuid absorption due to inhabiting
the N+ K+ APTase activity of intestinal tract and inhibiting the
mucosal cAMP-mediated active secretion. However, Castor oil
contains active component ricinoleic acid which is mostly
responsible for inducing diarrhoea through a hypersecretory
response [16].
Phytochemical observations of C. dactylon show the pres-
ences of ﬂavonoids, alkaloids, aminoacids, triterpenoids, phe-
nolics, coumarins, iridoids, polysaccharides, glycopeptides and
guanidines and sterols [7,12,17,18]. These chemicals are known to
be bioactive for the management of diabetes [19] and diarrhoea
[14]. It is well established that certain ﬂavonoids shows
hypoglycemic activity [20] and are also recognized for their
capability of beta cell regeneration of pancreas [21] and have
the ability to inhibit intestinal motility and hydroelectrolytic
secretions [22]. Sterols also have ability to reduce blood sugar
in experimental animal models [23]. Saponins, tannins,
ﬂavonoids, alkaloids and terpenes are shown as antidiarrhoeal
agents [24,25]. So, the signiﬁcant antidiabetic and antidiarrhoeal
effects of ethanolic extract of aerial parts of C. dactylon may
be due to the presence of more than one antihyperglycemic
and antidiarrhoeal principle, and their synergistic properties.
By this study we can ﬁnally afﬁrm that ethanolic extract of
aerial parts of C. dactylon has shown signiﬁcant effects to reduce
the BGL and increase ﬂuid accumulation of intestinal tract, and
act as antidiabetic and antidiarrhoeal agents. There was no acute
toxic effect at high dose level (4 g/kg body weight) of plant
extract that observed for 24 h and next 10 days investigation,
and there was no delayed toxic effects. Food consumption and
growth rate of experimented rats were also examined once daily
Md. Saidur Rahman et al./Asian Pac J Trop Biomed 2015; 5(8): 658–662662up to 10 days, and ﬁnally there was no abnormality. In addition,
pharmacological and biochemical investigations are ongoing to
explicate the mechanism of the antidiabetic and antidiarrhoeal
effects in C. dactylon.
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